title: The spectrum of aspergillosis in liver transplant patients: comparison of FK 506 and cyclosporine immunosuppression.
authors.affiliation: Department of Surgery, University of Pittsburgh, PA 15213.
authors.forename: J
authors.initials: J
authors.lastname: Torre-Cisneros
authors.forename: R
authors.initials: R
authors.lastname: Mañez
authors.forename: S
authors.initials: S
authors.lastname: Kusne
authors.forename: M
authors.initials: M
authors.lastname: Alessiani
authors.forename: M
authors.initials: M
authors.lastname: Martin
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
mesh_terms: D001228:Aspergillosis / Q000209:etiology*; D016572:Cyclosporine / Q000627:therapeutic use*; D006084:Graft Rejection; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects / Q000276:immunology*; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use; D012189:Retrospective Studies; D012307:Risk Factors; D016559:Tacrolimus / Q000627:therapeutic use*
chemical_list: D016853:Muromonab-CD3; D016572:Cyclosporine; D016559:Tacrolimus; D008775:Methylprednisolone